We found that FSHD-like expression of DUX4 is associated with muscle eosinophilia and elevated levels of eotaxin and eosinophil peroxidase, which may serve as new muscle biomarkers for FSHD pathology. This evidence concerns the gene CCL11 and facioscapulohumeral muscular dystrophy.